Blog
Drug Development
Articles filed under Drug Development, newest first.
Featured
15 Biologics are Going off Patent (2025–2029)
Global biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
Read article
Applying Complex Innovative Clinical Trial Designs to Orphan Drug Development
The design and development of orphan drugs, designed for rare diseases, are uniquely challenged as limited patient populations available for clinical trials.
Read article
Harnessing Continuous Data to Advance Clinical Discovery
Harnessing continuous data to accelerate clinical discovery, driving innovation with real-time insights and transformative solutions for healthcare breakthroughs.
Read article
Digital Era of Patient Engagement in Cardiometabolic Trials
Explore how digital tools are transforming patient engagement in cardiometabolic trials, enhancing recruitment, retention, and real-world data collection.
Read article
Understanding Orphan Medicine: A Lifeline for Rare Diseases
Exploring the benefits, challenges, and role play in medical innovation and patient care.
Read articlePage 3 of 4 · 18 articles
